Carmell Therapeutics (CTCX) Revenue & Revenue Breakdown
Carmell Therapeutics Revenue Highlights
Latest Revenue (Q)
$12.32K
Carmell Therapeutics Revenue by Period
Carmell Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | - |
Carmell Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Carmell Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $12.32K | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $-3.73M | -200.00% |
2023-09-30 | $3.73M | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | - |
Carmell Therapeutics generated $12.32K in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
CTCX Revenue FAQ
What is Carmell Therapeutics’s yearly revenue?
Carmell Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. CTCX's yearly revenue for 2021 was $0, representing an increase of 0% compared to 2020.
What is Carmell Therapeutics’s quarterly revenue?
Carmell Therapeutics's quarterly revenue for Q2 2024 was $12.32K, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). CTCX's quarterly revenue for Q4 2023 was $-3.729M, a -200.00% decrease from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Carmell Therapeutics’s revenue growth rate?
Carmell Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%